The Asia Pacific diabetes care devices market is expected to reach US$ 8,880.7 Mn in 2027 from US$ 5,011.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.
The growth of the market is driven by the factors such as, rapid technological advancements in diabetes care devices and increasing rate of obesity. However, the diabetes care devices market is likely to get impacted due to high cost of diabetes care devices and increasing prevalence of type 2 diabetes in the region.
Obesity is one of the major problem and the biggest concern in all the countries across the region. Currently, more than one in two adults and nearly one in six children are obese. Overweight and obesity is the abnormal or excessive fat accumulation in the body leading to impaired health. According to the MoHFW, Government of India, in India is approx. 60 million adults with diabetes (7.8% of the population), of which more than 30 million are undiagnosed or untreated anticipated in 2015. Thus, there is a higher increasing risk of developing complications and premature mortality. Obesity plays a major role in increasing diabetes among the population across the region. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes, cardiovascular disease (CVD), chronic respiratory illnesses, and diet-related cancers. According the data of National Health and Nutrition Examination Survey, in 2015-2016, the obesity rate between the youth of the age group between 2 to 19 is 18.5%. The rate varies among different age groups, with rates rising along with age. While overall obesity rates remain higher than they were a generation ago. Lack of exercise, unhealthy diet, and rapid growth in the obese population is expected to increase the susceptibility of diabetes among population in the region.
China is expected to lead the market in the Asia Pacific region owing to highest rate of incidences for the type 2 diabetes and increasing awareness in the country. However, rise in the prevalence of the diabetes is likely to add novel opportunities in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Rest of Asia Pacific Diabetes Care Devices Market Revenue and Forecasts to 2027 ( US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION
By Product
- Glucose Monitoring Devices
- Glucometers
- Lancets
- Testing Strips
- Other Glucose Monitoring Devices
- Insulin Delivery Devices
- Insulin Pens
- Insulin Syringes
- Insulin Pumps
- Other Insulin Delivery Devices
By End User
- Hospitals & Clinics
- Homecare
By Geography
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- BD
- Novo Nordisk A/S
- B. Braun Melsungen AG
- Insulet Corporation
- Medtronic
- Tandem Diabetes Care, Inc.
- Eli Lilly and Company
- Dexcom, Inc.
- Terumo Corporation
- F. Hoffman-LA Roche Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction. 17
1.1 Scope Of The Study. 17
1.2 The Insight Partners Research Report Guidance. 17
2. Asia Pacific Diabetes Care Devices Market – Key Takeaways. 19
3. Asia Pacific Diabetes Care Devices Market – Market Landscape. 23
3.1 Overview.. 23
3.2 Market Segmentation. 24
3.2.1 Asia Pacific Diabetes Care Devices Market – By Product 25
3.2.2 Asia Pacific Diabetes Care Devices Market – By End User 25
3.2.3 Asia Pacific Diabetes Care Devices Market – By Country. 25
3.3 PEST Analysis. 27
4. Asia Pacific Diabetes Care Devices Market - Key Market Dynamics. 31
4.1 Key Market Drivers. 31
4.1.1 Rapid Technological Advancements in Diabetes Care Devices. 31
4.1.2 Increasing Rate of Obesity. 31
4.2 Key Market Restraints. 32
4.2.1 High Cost of Diabetes Care Devices. 32
4.2.2 Increasing prevalence of Type 2 Diabetes. 33
4.3 Key Market Opportunities. 34
4.3.1 Growing Medical Tourism In Developing Countries. 34
4.4 Future Trends. 35
4.4.1 Increasing Prevalence of Obesity Across The Region. 35
4.5 Impact Analysis. 36
5. Diabetes Care Devices Market – Asia Pacific Analysis. 37
5.1 Asia Pacific Diabetes Care Devices Market Revenue Forecasts And Analysis. 37
5.2 Market Positioning. 38
5.3 Performance of Key Players. 38
5.3.1 Medtronic. 38
5.3.2 F. Hoffmann-La Roche Ltd. 39
6. Asia Pacific Diabetes Care Devices Market Analysis – By Product 40
6.1 Overview.. 40
6.2 Asia Pacific Diabetes Care Devices Market By Product, 2018 & 2027 (%) 40
6.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 41
6.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 41
6.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 42
6.4 Glucose Monitoring Devices Market 43
6.4.1 Overview.. 43
6.4.2 Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn) 43
6.4.3 Glucometers Market 44
6.4.3.1 Overview.. 44
6.4.3.2 Asia Pacific Glucometers Market Revenue and Forecast to 2027 (US$ Mn) 45
6.4.4 Lancets Market 46
6.4.4.1 Overview.. 46
6.4.4.2 Asia Pacific Lancets Market Revenue and Forecast to 2027 (US$ Mn) 46
6.4.5 Testing Strips Market 47
6.4.5.1 Overview.. 47
6.4.5.2 Asia Pacific Testing Strips Market Revenue and Forecast to 2027 (US$ Mn) 48
6.4.6 Other Glucose Monitoring Devices Market 49
6.4.6.1 Overview.. 49
6.4.6.2 Asia Pacific Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn) 49
6.5 Insulin Delivery Devices Market 51
6.5.1 Overview.. 51
6.5.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn) 51
6.5.3 Insulin Pens Market 53
6.5.3.1 Overview.. 53
6.5.3.2 Asia Pacific Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn) 53
6.5.4 Insulin Syringes Market 55
6.5.4.1 Overview.. 55
6.5.4.2 Asia Pacific Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn) 55
6.5.5 Insulin Pumps Market 57
6.5.5.1 Overview.. 57
6.5.5.2 Asia Pacific Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn) 57
6.5.6 Other Insulin Delivery Devices Market 58
6.5.6.1 Overview.. 58
6.5.6.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn) 59
7. Asia Pacific Diabetes Care Devices Market Analysis – By End User 60
7.1 Overview.. 60
7.2 Asia Pacific Diabetes Care Devices Market, By End User, 2018 & 2027 (%) 60
7.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 61
7.4 Homecare Market 62
7.4.1 Overview.. 62
7.4.2 Asia Pacific Homecare Market Revenue and Forecasts to 2027 (US$ Mn) 62
7.5 Hospitals & Clinics Market 64
7.5.1 Overview.. 64
7.5.2 Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 64
8. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027. 66
8.1 Overview.. 66
8.2 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 68
8.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 69
8.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 69
8.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 70
8.4 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 71
8.5 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%) 71
8.6 China Diabetes Care Devices Market 72
8.6.1 China Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 73
8.6.2 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 74
8.6.2.1 China Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 74
8.6.2.2 China Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 75
8.6.2.3 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 75
8.7 Japan Diabetes Care Devices Market 76
8.7.1 Japan Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 76
8.7.2 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 77
8.7.2.1 Japan Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 78
8.7.2.2 Japan Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 78
8.7.3 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 79
8.8 India Diabetes Care Devices Market 80
8.8.1 India Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 80
8.8.2 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 81
8.8.2.1 India Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 82
8.8.2.2 India Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 82
8.8.3 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 83
8.9 Australia Diabetes Care Devices Market 84
8.9.1 Australia Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 84
8.9.2 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 85
8.9.2.1 Australia Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 86
8.9.2.2 Australia Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 86
8.9.3 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 87
8.10 South Korea Diabetes Care Devices Market 88
8.10.1 South Korea Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 88
8.10.2 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn) 89
8.10.2.1 South Korea Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 90
8.10.2.2 South Korea Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn) 90
8.10.3 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn) 91
9. Diabetes Care Devices Market – Industry Landscape. 92
9.1 Overview.. 92
9.2 Comparative Company Analysis. 92
9.3 Growth Strategies Done By The Companies In The Market, (%) 94
9.4 Organic Developments. 95
9.4.1 Overview.. 95
9.5 Inorganic Developments. 97
9.5.1 Overview.. 97
10. Diabetes Care Devices Market–Key Company Profiles. 98
10.1 BD.. 98
10.1.1 Key Facts. 98
10.1.2 Business Description. 99
10.1.3 Financial Overview.. 100
10.1.4 Product Portfolio. 100
10.1.5 SWOT Analysis. 101
10.1.6 Key Developments. 101
10.2 Novo Nordisk A/S. 102
10.2.1 Key Facts. 102
10.2.2 Business Description. 102
10.2.3 Financial Overview.. 103
10.2.4 Product Portfolio. 104
10.2.5 SWOT Analysis. 104
10.2.6 Key Developments. 105
10.3 B. Braun Melsungen AG.. 106
10.3.1 Key Facts. 106
10.3.2 Business Description. 106
10.3.3 Financial Overview.. 107
10.3.4 Product Portfolio. 108
10.3.5 SWOT Analysis. 109
10.3.6 Key Developments. 109
10.4 Medtronic. 110
10.4.1 Key Facts. 110
10.4.2 Business Description. 110
10.4.3 Financial Information. 111
10.4.4 Product Portfolio. 112
10.4.5 SWOT Analysis. 113
10.4.6 Key Developments. 114
10.5 Tandem Diabetes Care, Inc. 116
10.5.1 Key Facts. 116
10.5.2 Business Description. 116
10.5.3 Financial Information. 117
10.5.4 Product Portfolio. 117
10.5.5 SWOT Analysis. 118
10.5.6 Key Developments. 119
10.6 Insulet Corporation. 121
10.6.1 Key Facts. 121
10.6.2 Business Description. 121
10.6.3 Financial Information. 122
10.6.4 Product Portfolio. 123
10.6.5 SWOT Analysis. 123
10.6.6 Key Developments. 124
10.7 Eli Lilly And Company. 126
10.7.1 Key Facts. 126
10.7.2 Business Description. 126
10.7.3 Financial Overview.. 127
10.7.4 Product Portfolio. 128
10.7.5 SWOT Analysis. 128
10.7.6 Key Developments. 129
10.8 Dexcom, Inc. 130
10.8.1 Key Facts. 130
10.8.2 Business Description. 130
10.8.3 Financial Overview.. 131
10.8.4 Product Portfolio. 131
10.8.5 SWOT Analysis. 133
10.8.6 Key Developments. 134
10.9 Terumo Corporation. 135
10.9.1 Key Facts. 135
10.9.2 Business Description. 135
10.9.3 Financial Overview.. 136
10.9.4 Product portfolio. 137
10.9.5 SWOT ANALYSIS. 137
10.9.6 KEY DEVELOPMENTS. 138
10.10 F. Hoffmann-La Roche Ltd. 139
10.10.1 Key Facts. 139
10.10.2 Business Description. 139
10.10.3 Financial Overview.. 140
10.10.4 Product Portfolio. 141
10.10.5 SWOT Analysis. 142
10.10.6 Key Developments. 143
11. Appendix. 144
11.1 About The Insight Partners. 144
11.2 Glossary Of Terms. 145
11.3 Methodology. 148
11.3.1 Coverage. 150
11.3.2 Secondary Research. 150
11.3.3 Primary Research. 151
LIST OF TABLES
Table 1. Obese Population Across The Region, 2017. 35
Table 2. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 41
Table 3. Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 41
Table 4. Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 42
Table 5. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 61
Table 6. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 69
Table 7. Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 69
Table 8. Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 70
Table 9. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 71
Table 10. China Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 74
Table 11. China Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 74
Table 12. China Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 75
Table 13. China Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 75
Table 14. Japan Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 77
Table 15. Japan Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 78
Table 16. Japan Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 78
Table 17. Japan Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 79
Table 18. India Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 81
Table 19. India Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 82
Table 20. India Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 82
Table 21. India Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 83
Table 22. Australia Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 85
Table 23. Australia Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 86
Table 24. Australia Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 86
Table 25. Australia Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 87
Table 26. South Korea Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn) 89
Table 27. South Korea Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 90
Table 28. South Korea Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (Us$ Mn) 90
Table 29. South Korea Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn) 91
Table 30. Organic Developments Done By Companies. 96
Table 31. Inorganic Developments Done By Companies. 97
Table 32. Glossary Of Terms, Diabetes Care Devices Market 145
LIST OF FIGURES
Figure 1. China Diabetes Care Devices Market, Revenue (Us$ Mn), By Country 2018 & 2027. 20
Figure 2. Asia Pacific Diabetes Care Devices Market By Product, Market Share (%), 2018. 21
Figure 3. Asia Pacific Diabetes Care Devices Market By End User, Market Share (%), 2018. 22
Figure 4. Diabetes Care Devices Market Segmentation. 24
Figure 5. Asia Pacific PEST Analysis. 27
Figure 6. Diabetes Care Devices Market Impact Analysis Of Drivers & Restraints. 36
Figure 7. Asia Pacific Diabetes Care Devices Market – Revenue Forecasts And Analysis – 2018- 2027. 37
Figure 8. Asia Pacific Diabetes Care Devices Market, By Product 2018 & 2027 (%) 40
Figure 9. Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 44
Figure 10. Asia Pacific Glucometers Market Revenue And Forecasts To 2027 (Us$ Mn) 45
Figure 11. Asia Pacific Lancets Market Revenue And Forecasts To 2027 (Us$ Mn) 47
Figure 12. Asia Pacific Testing Strips Market Revenue And Forecasts To 2027 (Us$ Mn) 48
Figure 13. Asia Pacific Other Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 50
Figure 14. Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 52
Figure 15. Asia Pacific Insulin Pens Market Revenue And Forecasts To 2027 (Us$ Mn) 54
Figure 16. Asia Pacific Insulin Syringes Market Revenue And Forecasts To 2027 (Us$ Mn) 56
Figure 17. Asia Pacific Insulin Pumps Market Revenue And Forecasts To 2027 (Us$ Mn) 58
Figure 18. Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 59
Figure 19. Asia Pacific Diabetes Care Devices Market By End User, 2018 & 2027 (%) 60
Figure 20. Asia Pacific Homecare Market Revenue And Forecasts To 2027 (Us$ Mn) 63
Figure 21. Asia Pacific Hospitals & Clinics Market Revenue And Forecasts To 2027 (Us$ Mn) 65
Figure 22. Asia Pacific Diabetes Care Devices Market Revenue Overview, By Country, 2018 (Us$ Mn) 67
Figure 23. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 68
Figure 24. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%) 71
Figure 25. China Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 73
Figure 26. Japan Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 77
Figure 27. India Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 81
Figure 28. Australia Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 85
Figure 29. South Korea Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn) 89
Figure 30. Comparative Company Analysis. 92
Figure 31. Growth Strategies Done By The Companies In The Market, (%) 94
- BD
- Novo Nordisk A/S
- B. Braun Melsungen AG
- Insulet Corporation
- Medtronic
- Tandem Diabetes Care, Inc.
- Eli Lilly and Company
- Dexcom, Inc.
- Terumo Corporation
- F. Hoffman-LA Roche Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Diabetes Care Devices Market
Jun 2019
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jun 2019
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2019
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jun 2019
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)